Which medication should be adjusted due to the patient's symptoms of lightheadedness, dizziness, and fatigue, likely caused by hypotension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hypotension in a 90-Year-Old Patient with Cardiovascular Disease

Based on the patient's symptoms of lightheadedness, dizziness, fatigue, and documented hypotension (BP 85/59), lisinopril should be reduced or discontinued as the first intervention.

Assessment of Current Symptoms

  • The patient presents with constant dizziness, lightheadedness affecting her eyes, inability to keep eyes open during dizzy episodes, fatigue, documented hypotension (85/59), and episodes of falling asleep for 2-3 hours 1
  • These symptoms are consistent with symptomatic orthostatic hypotension, which is defined as a reduction in systolic BP of at least 20 mmHg or diastolic BP of at least 10 mmHg within 3 minutes of standing 1
  • The symptoms are interfering with activities of daily living and are not improving despite reduction in isosorbide mononitrate dosage 1

Medication Analysis and Recommendations

Primary Target for Adjustment:

  • Lisinopril 20 mg twice daily should be reduced or discontinued as it is the most likely cause of the patient's symptomatic hypotension 1
  • ACE inhibitors like lisinopril commonly cause hypotension, especially in elderly patients and those on multiple cardiovascular medications 2
  • The patient is on a high dose (20 mg twice daily), which exceeds the typical starting dose for heart failure (5 mg once daily) 2

Rationale for Targeting Lisinopril:

  • When symptomatic hypotension occurs with dizziness and lightheadedness, the European Journal of Heart Failure recommends reconsidering the need for ACE inhibitors before other vasodilators 1
  • The American Heart Association guidelines specifically state that if hypotension is accompanied by clinical evidence of hypoperfusion, ACE inhibitor therapy should be decreased or discontinued pending further evaluation 1
  • Elderly patients (≥90 years) are particularly susceptible to hypotension from ACE inhibitors due to decreased baroreceptor response and increased drug sensitivity 3

Secondary Considerations:

  • If reducing lisinopril is insufficient:
    • Consider reducing bisoprolol (10 mg daily) as beta-blockers can also cause bradycardia and hypotension 1, 4, 3
    • Isosorbide mononitrate (already reduced) may need further adjustment or discontinuation as nitrates are potent vasodilators 1

Implementation Plan

  1. First step: Reduce lisinopril to 5-10 mg once daily or discontinue completely based on clinical response 1, 2
  2. Monitoring: Check orthostatic blood pressures (lying and standing) at follow-up visits to document improvement 1
  3. If symptoms persist: Consider further reducing or discontinuing bisoprolol, especially if bradycardia is present (heart rate <50 bpm) 1, 4, 3
  4. Medication timing: If partial doses are maintained, administer beta-blockers and ACE inhibitors at different times of the day to minimize hypotensive effects 1

Special Considerations for This Patient

  • Advanced age (90 years) increases susceptibility to medication-induced hypotension 1, 3
  • Multiple cardiovascular conditions and medications create higher risk for drug interactions and adverse effects 1
  • The patient's extensive vascular disease (carotid stenosis, CAD, PAD) may impair autoregulation of blood pressure 1, 5
  • Ambulatory monitoring with a cane indicates mobility concerns, which increases fall risk with hypotension 1

Potential Pitfalls and Precautions

  • Abrupt withdrawal of beta-blockers should be avoided; if bisoprolol needs adjustment, it should be tapered gradually 1, 3
  • Monitor for worsening heart failure symptoms if cardiovascular medications are reduced 1
  • Consider that the patient's symptoms could have multiple causes beyond medication effects, including carotid disease and cardiac arrhythmias 1, 6
  • The patient's telemonitoring results show pauses and SVT runs, which could contribute to symptoms and should be monitored during medication adjustments 7, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Bradycardia in Elderly Patients on Beta-Blockers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Causes of Dizziness in Patients Taking Beta Blockers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Orthostatic Hypotension in the Hypertensive Patient.

American journal of hypertension, 2018

Research

Dizziness: a diagnostic approach.

American family physician, 2010

Guideline

Management of Beta Blocker Therapy in First-Degree AV Block

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.